Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resection

[1]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[2]  K. Eguchi,et al.  The level of fasting serum insulin, but not adiponectin, is associated with the prognosis of early stage hepatocellular carcinoma. , 2009, Oncology reports.

[3]  A. Poliakov,et al.  Adipose Tissue Exosome-Like Vesicles Mediate Activation of Macrophage-Induced Insulin Resistance , 2009, Diabetes.

[4]  Manal M. Hassan,et al.  Antidiabetic therapies affect risk of pancreatic cancer. , 2009, Gastroenterology.

[5]  J. Meyerhardt,et al.  Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  G. Marchesini,et al.  Retinol‐binding protein 4: A new marker of virus‐induced steatosis in patients infected with hepatitis c virus genotype 1 , 2008, Hepatology.

[7]  Zhao-You Tang,et al.  High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Q. Ye,et al.  Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. , 2007, Journal of hepatology.

[9]  Bounleut Phanavanh,et al.  Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. , 2007, The Journal of clinical endocrinology and metabolism.

[10]  F. Tacke,et al.  Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. , 2007, Diabetes care.

[11]  F. Hu,et al.  Lipocalins and insulin resistance: etiological role of retinol-binding protein 4 and lipocalin-2? , 2007, Clinical chemistry.

[12]  Arya M. Sharma,et al.  Retinol-Binding Protein 4 in Human Obesity , 2006, Diabetes.

[13]  F. Berrino,et al.  Metabolic syndrome as a prognostic factor for breast cancer recurrences , 2006, International journal of cancer.

[14]  U. Smith,et al.  Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. , 2006, The New England journal of medicine.

[15]  Zhao-You Tang.  Hepatocellular carcinoma surgery–review of the past and prospects for the 21st century , 2005, Journal of surgical oncology.

[16]  Nimesh Mody,et al.  Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes , 2005, Nature.

[17]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[18]  J. Lewis,et al.  Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. , 2004, Gastroenterology.

[19]  Yan Li,et al.  Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics , 2004, Journal of Cancer Research and Clinical Oncology.

[20]  Moritoshi Kinoshita,et al.  Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci , 2002, Hepatology.

[21]  S. Fan,et al.  Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  B. Hoffman,et al.  Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  A. Medline,et al.  Possible mechanisms relating diet and risk of colon cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  E. Riboli,et al.  Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. , 2000, Journal of the National Cancer Institute.

[25]  S. Ye,et al.  New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis , 1999, British Journal of Cancer.

[26]  L. Li,et al.  [Research on characteristics of mortality spectrum and type composition of malignant tumors in China]. , 1997, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[27]  Zeng-chen Ma,et al.  Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues , 1996, International journal of cancer.